Catalio Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001958125

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024

Q3 2026 · 46 positions · Total reported value $535.82M · Top-10 concentration 48.7% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 63.5% · 13 new · 14 cut · 6 exited

Active Share (vs S&P 500): 98.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q3 2026 13F filing, Catalio Capital Management, LP disclosed 46 equity positions with a combined reported value of $535.82M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.7% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were AVLN ($48.40M), BMY ($31.18M), BBIO ($27.97M). By sector, the heaviest allocations are Health Care 96.3%, Industrials 2.8%. Versus the prior quarter, allocation shifted toward Industrials (+2.8pp) and away from Other (-0.7pp), Health Care (-2.0pp).

Versus the prior quarter, Catalio Capital Management, LP opened 13 new positions, trimmed 14 and fully exited 6, a turnover rate of 63.5% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q3 2026 were ARWR ($20.63M), CELC ($18.34M), GH ($16.51M).

Of the 6 positions fully exited versus the prior quarter, the largest were GILD ($34.02M), INCY ($21.72M), AXSM ($10.57M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ARWR ARROWHEAD PHARMACEUTICALS IN · $20.63M
  • CELC CELCUITY INC · $18.34M
  • GH GUARDANT HEALTH INC · $16.51M
  • TXG 10X GENOMICS INC · $14.82M
  • AMLX AMYLYX PHARMACEUTICALS INC · $14.72M
  • ENTX ENTERA BIO LTD · $11.41M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $8.70M
  • ANNX ANNEXON INC · $8.40M

Fully Exited (vs previous quarter)

  • GILD GILEAD SCIENCES INC · prev qtr: $34.02M
  • INCY INCYTE CORP · prev qtr: $21.72M
  • AXSM AXSOME THERAPEUTICS INC. · prev qtr: $10.57M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $5.44M
  • DNTH DIANTHUS THERAPEUTICS INC · prev qtr: $3.21M
  • ATAI ATAI LIFE SCIENCES NV · prev qtr: $1.04M

Insider Transactions (Form 4)

Latest Catalio Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 742,546 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,458,290 — SEC filing
2026-10-16 Conversion Iambic Therapeutics, Inc. 1,995,749 — SEC filing

All insider transactions →

Fund Profile

Catalio Capital Management, LP is an SEC-registered 13F filer based in New York, NY, United States. As of Q3 2026 it reported 46 US equity positions with a combined value of $535.82M. HoldingsHub carries 8 quarters of its filings (Q4 2024–Q3 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-121976 (status: Approved), registered 2021-07-30
  • Regulatory AUM (Form ADV): $1.93B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 78%, pooled investment vehicles 13%
  • Manages 23 private funds, of which 1 hedge funds

Portfolio Structure

  • 46 positions · $535.82M reported value (Q3 2026)
  • Top 10 holdings = 48.7% of reported value
  • Largest position: AVLN (AVALYN PHARMACEUTICALS INC) at 9.0%
  • Average position size: $11.65M

Sector Tilt

  • Health Care 96.3%
  • Industrials 2.8%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q3 2026: 13 new, 13 added, 14 reduced, 6 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is cautiously bullish on healthcare, selectively adding large-cap pharma (BMY, JNJ) while reducing smaller biotech names (BBIO, SNDX, DFTX), suggesting a preference for stability over high-risk growth. 2. Key moves: - Added: BMY (21% share increase), ASND (219% share increase), AVLN (1.4% share increase). - Reduced: JNJ (-28.4% shares), BBIO (-6.6% shares), SNDX (-15.8% shares), DFTX (-11.5% shares). - New positions: ARWR, CELC. 3. Portfolio structure: Active, healthcare-focused (100% sector), moderate risk appetite (mix of large-cap pharma and speculative biotech). 4. Per-holding one-liner: - AVLN: Avelyn Pharmaceuticals (biotech, unverified). - BMY: Bristol-Myers Squibb (large-cap pharma). - BBIO: BridgeBio Pharma (biotech, unverified). - PBLS: Parabilis Medicines (biotech, unverified). - JNJ: Johnson & Johnson (large-cap pharma). - ASND: Ascendis Pharma (biotech, unverified). - ARWR: Arrowhead Pharmaceuticals (biotech, unverified). - SNDX: Syndax Pharmaceuticals (biotech, unverified). - DFTX: Definium Therapeutics (biotech, unverified). - CELC: Celcuity (biotech, unverified). 5. Style summary: The fund rotated toward large-cap healthcare stability while trimming speculative biotech, adding new positions in high-growth biotech.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 11:38

Sector Allocation

Health Care 96.3%
Other 0.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.70M $48.40M 9.03%
9.03%
Add
2 499.72K $31.18M 5.82%
5.82%
Add
3 425.11K $27.97M 5.22%
5.22%
Reduce
4 824.04K $26.61M 4.97%
4.97%
Hold
5 99.50K $26.34M 4.92%
4.92%
Reduce
6 101.44K $23.11M 4.31%
4.31%
Add
7 315.25K $20.63M 3.85%
3.85%
New
8 1.02M $19.24M 3.59%
3.59%
Reduce
9 497.96K $18.95M 3.54%
3.54%
Reduce
10 230.61K $18.34M 3.42%
3.42%
New
11 454.01K $17.77M 3.32%
3.32%
Reduce
12 92.58K $16.51M 3.08%
3.08%
New
13 112.42K $15.84M 2.96%
2.96%
Add
14 164.03K $14.82M 2.77%
2.77%
New
15 505.88K $14.72M 2.75%
2.75%
New
16 583.36K $14.66M 2.74%
2.74%
Reduce
17 161.12K $13.91M 2.60%
2.60%
Add
18 1.02M $11.77M 2.20%
2.20%
Reduce
19 95.65K $11.60M 2.16%
2.16%
Add
20 3.92M $11.41M 2.13%
2.13%
New
21 172.71K $11.31M 2.11%
2.11%
Add
22 457.84K $10.17M 1.90%
1.90%
Hold
23 684.75K $9.80M 1.83%
1.83%
Add
24 601.76K $9.04M 1.69%
1.69%
Add
25 144.97K $8.70M 1.62%
1.62%
New
26 1.99M $8.40M 1.57%
1.57%
New
27 85.61K $8.15M 1.52%
1.52%
New
28 260.11K $8.13M 1.52%
1.52%
Reduce
29 126.82K $7.68M 1.43%
1.43%
New
30 211.99K $6.42M 1.20%
1.20%
Add
31 167.72K $5.37M 1.00%
1.00%
New
32 468.75K $5.35M 1.00%
1.00%
Hold
33 12.53K $5.18M 0.97%
0.97%
Reduce
34 8.84M $4.81M 0.90%
0.90%
Add
35 312.50K $4.61M 0.86%
0.86%
Hold
36 1.64M $4.14M 0.77%
0.77%
Reduce
37 74.97K $3.73M 0.70%
0.70%
Reduce
38 699.53K $2.87M 0.54%
0.54%
Add
39 87.70K $2.81M 0.52%
0.52%
New
40 512.29K $1.56M 0.29%
0.29%
Reduce
41 976.19K $1.19M 0.22%
0.22%
Add
42 1.30M $1.05M 0.20%
0.20%
Reduce
43 528.99K $560.73K 0.10%
0.10%
Hold
44 14.72K $437.71K 0.08%
0.08%
Hold
45 107.46K $322.37K 0.06%
0.06%
Reduce
46 11.36K $226.46K 0.04%
0.04%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 34% of its Top-10 each quarter and backtests at F1 67% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (6 quarters)

Avg precision 67% · recall 67% · F1 67% · avg rank error 3.9 · Top-10 turnover 34%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2025-Q2 70% 70% 70% BDX · BBIO · EW · SWTX · ASND · VCYT · CYTK · SNDX · LLY · ISRG LLY · BBIO · SLNO · ASND · ISRG · EW · GILD · BSX · CYTK · SNDX
2025-Q3 80% 80% 80% LLY · BBIO · SLNO · ISRG · EW · ASND · BSX · GILD · SNDX · CYTK LLY · ABBV · BBIO · ISRG · ASND · SLNO · DNTH · BSX · SNDX · CYTK
2025-Q4 60% 60% 60% LLY · ABBV · ISRG · SLNO · BBIO · BSX · ASND · NTRA · DNTH · SNDX GILD · BMY · BSX · BBIO · LLY · DNTH · ASND · SNDX · JNJ · REGN
2026-Q1 70% 70% 70% BMY · GILD · BSX · BBIO · LLY · DNTH · REGN · JNJ · ASND · SNDX DNTH · BBIO · ASND · BMY · SNDX · GILD · TERN · DFTX · SLNO · BSX
2026-Q2 50% 50% 50% DNTH · BBIO · ASND · BMY · TERN · SNDX · GILD · SLNO · RARE · DFTX AVLN · JNJ · GILD · BBIO · SNDX · DFTX · BMY · PBLS · NTRA · INCY
2026-Q3 ★ 70% 70% 70% AVLN · JNJ · GILD · BBIO · SNDX · DFTX · NTRA · BMY · PBLS · INCY AVLN · BMY · BBIO · PBLS · JNJ · ASND · ARWR · SNDX · DFTX · CELC

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings9 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-6.95%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return+10.07%vs benchmark
Barra annualised vol27.5%Model estimate
Realised vol28.9%Annualised in window
Weighted beta0.71Raw exposure
Factor / specific risk63% / 37%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-16Catalio Capital Management, LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-6.95%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return+10.07%Portfolio − benchmark
Arithmetic return sum-6.65%Difference vs compounded is the cross term
Weighted raw beta0.71Weighted holding betas
Realised volatility (annualised)28.93%Daily returns in window
Barra model volatility (annualised)27.49%Factor + specific
Factor share of variance62.7%Barra factors
Specific share of variance37.3%Stock residuals
Reported value$156.2M13F long US equity

2. Return attribution

The -6.65% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +1.05% 15.8%
Momentum & Growth 3 -5.38% -80.9%
Volatility & Tail Risk 7 -1.63% -24.5%
Industry 12 +6.34% 95.3%
Specific 1 -7.03% -105.8%
Return attribution (style + industry, %)-6.8-3.4+0.0+3.4+6.8Amihud Illiquidity-0.43Leverage (Downside Vol)+0.44Turnover+0.67Beta-0.72Kurtosis+0.74Non-linear Size+0.98Max Drawdown-1.36Size+1.41Skewness-1.60Mid Cap-1.70Historical Volatility-2.44Residual Volatility+3.32Momentum-5.47Health Care+6.32
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.91 +6.98% +6.32% 95.0%
Residual Volatility Style +1.01 +3.29% +3.32% 49.9%
Size Style -0.72 -1.95% +1.41% 21.2%
Non-linear Size Style +0.98 +1.01% +0.98% 14.8%
Kurtosis Style +0.10 +7.51% +0.74% 11.2%
Turnover Style -0.14 -4.80% +0.67% 10.1%
Leverage (Downside Vol) Style -0.25 -1.71% +0.44% 6.5%
Short-term Reversal Style +0.14 +0.87% +0.13% 1.9%
Liquidity Style +0.31 +0.36% +0.11% 1.7%
Amihud Illiquidity Style +0.96 -0.45% -0.43% -6.5%
Beta Style -0.16 +4.44% -0.72% -10.9%
Max Drawdown Style +0.77 -1.76% -1.36% -20.5%
Skewness Style +0.36 -4.39% -1.60% -24.1%
Mid Cap Style +0.88 -1.94% -1.70% -25.6%
Historical Volatility Style +0.17 -14.00% -2.44% -36.8%
Momentum Style +1.37 -4.00% -5.47% -82.3%
Specific Specific — — -7.03% -105.8%

3. Risk attribution

Annualised volatility is 27.49%; factor risk explains 62.7% of variance and specific risk 37.3%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-40.3-20.1+0.0+20.1+40.3Beta-2.35Skewness-1.56Non-linear Size-1.09Leverage (Downside Vol)+0.76Short-term Reversal+0.80Amihud Illiquidity+1.35Industrials+1.64Mid Cap+3.91Residual Volatility+4.61Size+4.68Max Drawdown+4.87Momentum+15.33Health Care+29.24Specific+37.30
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 37.3% +10.25% 10.2%
Health Care Industry +0.91 29.2% +8.04% 8.0%
Momentum Style +1.37 15.3% +4.21% 4.2%
Max Drawdown Style +0.77 4.9% +1.34% 1.3%
Size Style -0.72 4.7% +1.29% 1.3%
Residual Volatility Style +1.01 4.6% +1.27% 1.3%
Mid Cap Style +0.88 3.9% +1.08% 1.1%
Industrials Industry +0.09 1.6% +0.45% 0.5%
Amihud Illiquidity Style +0.96 1.4% +0.37% 0.4%
Short-term Reversal Style +0.14 0.8% +0.22% 0.2%
Leverage (Downside Vol) Style -0.25 0.8% +0.21% 0.2%
Liquidity Style +0.31 0.4% +0.12% 0.1%
Historical Volatility Style +0.17 0.3% +0.09% 0.1%
Non-linear Size Style +0.98 -1.1% -0.30% -0.3%
Skewness Style +0.36 -1.6% -0.43% -0.4%
Beta Style -0.16 -2.4% -0.65% -0.7%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.0-0.20.71.52.4Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.72 +2.10 -2.82
Non-linear Size +0.98 +1.68 -0.70
Mid Cap +0.88 +0.13 +0.75
Beta -0.16 +1.29 -1.46
Momentum +1.37 +0.72 +0.65
Short-term Reversal +0.14 -0.64 +0.79
Residual Volatility +1.01 -0.40 +1.41
Historical Volatility +0.17 +0.86 -0.69
Liquidity +0.31 +0.11 +0.20
Amihud Illiquidity +0.96 +1.16 -0.19
Turnover -0.14 +0.21 -0.35
Growth -0.02 +0.58 -0.60
Leverage (Downside Vol) -0.25 +0.14 -0.40
Skewness +0.36 +0.24 +0.13
Kurtosis +0.10 +0.21 -0.12
Max Drawdown +0.77 -0.08 +0.86

5. Industry allocation & Brinson

Industry allocation (weight, %)-9.118.145.372.499.6Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Health Care 90.5% 1.7% -2.75% +8.29% +22.57% -0.19% -9.80% -2.63%
Industrials 9.5% 11.1% -39.14% +4.36% -0.35% -4.83% +0.70% -4.20%
Total +23.61% +11.30% -25.42% +9.50%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
BMY BRISTOL-MYERS SQUIBB CO Health Care 19.97% +1.89% +0.38% Add
BBIO BRIDGEBIO PHARMA INC Health Care 17.91% +17.57% +3.15% Reduce
JNJ JOHNSON & JOHNSON Health Care 16.87% +6.73% +1.14% Reduce
GH GUARDANT HEALTH INC Health Care 10.57% -19.25% -2.04% New
PTGX PROTAGONIST THERAPEUTICS INC Health Care 10.14% -11.40% -1.16% Add
TXG 10X GENOMICS INC Industrials 9.49% -39.14% -3.72% New
ODTX ODYSSEY THERAPEUTICS INC Health Care 6.51% -12.87% -0.84% Hold
GPCR STRUCTURE THERAPEUTICS INC Health Care 5.21% -40.61% -2.11% Reduce
NTRA NATERA INC Health Care 3.32% -30.20% -1.00% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 BBIO Health Care 17.91% +17.57% +3.15%
2 JNJ Health Care 16.87% +6.73% +1.14%
3 BMY Health Care 19.97% +1.89% +0.38%
4 ODTX Health Care 6.51% -12.87% -0.84%
5 NTRA Health Care 3.32% -30.20% -1.00%
6 PTGX Health Care 10.14% -11.40% -1.16%
7 GH Health Care 10.57% -19.25% -2.04%
8 GPCR Health Care 5.21% -40.61% -2.11%
9 TXG Industrials 9.49% -39.14% -3.72%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -6.95%, versus -17.01% for the QQQ synthetic benchmark — an excess of +10.07%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +6.32%, Residual Volatility +3.32%, Size +1.41%; the largest drags came from Momentum -5.47%, Historical Volatility -2.44%, Mid Cap -1.70%. Specific (stock-level) return contributed -7.04%.
  3. Risk attribution: Barra model volatility is 27.49% annualised; factor risk explains 63% of variance and specific risk 37%. The largest factor risk sources are Health Care 29.2%, Momentum 15.3%, Max Drawdown 4.9%.
  4. Style tilt: size -0.72, momentum +1.37, volatility +0.17, liquidity +0.31; the weighted raw beta is 0.71. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+88.8 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +23.61%, selection +11.30% and interaction -25.42%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Catalio Capital Management, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Catalio Capital Management, LP reported 46 equity positions worth $535.82M in aggregate; its largest disclosed positions were AVLN ($48.40M), BMY ($31.18M), BBIO ($27.97M).

How large is Catalio Capital Management, LP's portfolio?

Catalio Capital Management, LP reported $535.82M of long equity holdings across 46 positions as of 2026-Q3. Top-10 holdings account for 48.7% of reported value.

What is Catalio Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/catalio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →